Ann: Intention to launch Share Purchase Plan, page-60

Helli y'all,

i have been busier than a politician reading a book without pictures the last two weeks, so haven't had a lot of time to keep up with things.

it's nice to see some discussion on the ANP threads.

We are in a very exciting development period for ANP. We are at the point where the company needs to prove their drug works. We have evidence from a previous trial that it does. We have a better understanding of how it works now, have identified the associated biomarkers, and have patents that give protection through a multitude of inflammation diseases.

Success in this trial opens up a plethora of treatments for ATL1102, making it a platform drug.

So its time to put up or shut up for the company, with respect the drug working. We have the world expert into DMD as the trials PI, we have some members of the board that have moved on over from CSL. We have a market cap that is multiples below where a drug this far advanced would have been two/three years ago.

So in essence, now that finance has been sorted our risk changes/reduces to "does the drug work?". If it does the reward will be tens of multiples from where we are now. And we find that out next year.

The foundation to spinning off into other indications has already been laid.

Exciting times ahead.